Mylan Pharmaceuticals (MYL) Receives FDA Approval for Generic Requip
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Mylan Pharmaceuticals (MYL) Receives FDA Approval for Generic Requip
7 May 08, 12:47
Mylan Pharmaceuticals (NYSE: MYL) has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ...
more

 

 
© 2007 nafdacnigeria.org